AstraZeneca Settles Nexium Case With Ranbaxy; Can It Delay Other Generics?

AstraZeneca expects its settlement agreement with Ranbaxy ending Nexium (esomeprazole) patent infringement litigation will win a nod of approval from the Federal Trade Commission